The award, which was voted on by biopharmaceutical customers in Korea, was delivered during the Korea Bioprocessing Excellence Awards 2020 event, held virtually on October 21-22, 2020.
The Korea Bioprocessing Excellence Awards 2020 event aims to recognize outstanding bioprocessing professionals, organizations, and technologies that facilitate biomanufacturing excellence at enhanced speeds, reduced costs, and superior quality. The event brought together top bioprocessing and biomanufacturing experts along with the latest advancements in technologies and best practices.
Nominees for the Bioprocessing Excellence Award in Innovative Single-Use Solutions in Korea accolade included CPC, Foxx Life Sciences, ILC Dover, Millipore Sigma, and Repligen. Louis Wong, Technical Sales Director for Asia at ILC Dover, received the award on ILC Dover’s behalf, which can be watched here.
In his acceptance speech, Louis commented on ILC Dover’s recent acquisition of Solo Containment, a UK-based Company which has pioneered single-use aseptic processing isolators using uni-directional high-volume airflows. The combined capability set between ILC Dover and Solo will enable pharmaceutical and biopharmaceutical manufacturers to further eliminate costly cleaning processes and achieve maximum productivity and safety without sacrificing reliability.
Currently, ILC Dover’s single-use powder, hydration, and liquid handling solutions for biopharmaceutical containment include EZ BioPac®, DoverPac®, Continuous Liners, Flexible Isolators, and Flexible Enclosures. For the pharmaceutical market, our single-use flexible powder solutions for high containment include Flexible Isolators, DoverPac®, Continuous Liners, Flexible Enclosures, Drum Liners/Sleeves, and the Atmospheric Control Module (ACM).
Thank you BMK 2020 for recognizing ILC Dover with this prestigious award.
Watch the full awards ceremony and ILC Dover’s acceptance speech here.